Developing Ultra-High Throughput Cellular Screening of Covalent Libraries & the Advancement of a PI3K-alpha Covalent Inhibitor
Time: 12:30 pm
day: Conference Day One
Details:
Elucidating the development of the first ever platform to screen billions of covalent compounds in cells in days
Discussing the discovery of TOS-358, the first highly specific covalent inhibitor of PI3K-alpha
Case Study: The unique properties and advantages of covalent targeting of PI3K-alpha
